Theratechnologies Inc. (THTX) Financials
THTX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-02-29 | 72.0 million | 96.6 million |
2023-11-30 | 77.8 million | 98.6 million |
2023-08-31 | 56.7 million | 98.4 million |
2023-05-31 | 68.7 million | 110.3 million |
THTX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-02-29 | -1.7 million | ? |
2023-11-30 | -5.6 million | 418000 |
2023-08-31 | 5.3 million | 519000 |
2023-05-31 | -3.6 million | 702000 |
THTX Net Income
No data available :(
THTX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-02-29 | 38.4 million | - | - |
2023-11-30 | 40.4 million | - | 994000 |
2023-08-31 | 22.9 million | - | 1.1 million |
2023-05-31 | 25.4 million | - | 1.2 million |
THTX Shares Outstanding
THTX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-02-29 | - | 3.7 million | - | - |
2023-11-30 | 1.5 million | 5.2 million | 3.7 million | 6.7 million |
2023-08-31 | 15000 | 5.4 million | 3.7 million | 6.7 million |
2023-05-31 | 81000 | 10.4 million | 3.7 million | 6.5 million |
THTX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-02-29 | 16.1 million | 5.7 million |
2023-11-30 | 23.5 million | 5.1 million |
2023-08-31 | 20.9 million | 5.0 million |
2023-05-31 | 17.5 million | 4.9 million |
THTX
Price: $1.28
52 week price:
Earnings Per Share: -0.91 USD
P/E Ratio: -1.33
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 5200
Market Capitalization: 60.1 million